...and forms an “epichaperome.” For proof of concept, her team generated a radiolabeled version of Samus Therapeutics Inc.’s...

...affairs at TG Therapeutics Inc. (NASDAQ:TGTX) and Morgan was chief regulatory/quality and contracting officer of Samus Therapeutics Inc....

...vehicle. Next steps could include optimizing and testing the inhibitor in additional models of UC. Samus Therapeutics Inc....

...against apoptosis. Next steps could include evaluating the selective Hsp90 inhibitor in animal cancer models. Samus Therapeutics...
...Published online Oct. 3, 2013 Patent application filed covering purine-scaffold Hsp90 inhibitors; PU-H71 licensed to Samus Therapeutics...

...2011 PxRadia Inc. Scottsdale, Ariz. Anti-ceramide antibody for GI syndrome and other inflammatory conditions 2011 Samus Therapeutics...